Partillion Bioscience Announces Early Access Program for Nanovial Multicell Assays to Enable the Study of Cell-to-Cell Interactionsnews2024-08-21T14:31:59+00:00August 21st, 2024|Medical Device News Magazine|
International Consortium to Revolutionize Viral Vector Manufacturing | Reports VVector Bionews2024-08-20T13:25:21+00:00August 20th, 2024|Medical Device News Magazine|
Qubit Pharmaceuticals nominated for “Best start-up 2024” award by Prix Galien USAnews2024-08-20T13:11:19+00:00August 20th, 2024|Medical Device News Magazine|
TEPKINLY (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults with Relapsed/Refractory Follicular Lymphomanews2024-08-19T18:31:29+00:00August 19th, 2024|Medical Device News Magazine|
Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer Therapeuticnews2024-08-15T12:33:30+00:00August 15th, 2024|Medical Device News Magazine|
NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccinesnews2024-08-08T04:03:09+00:00August 8th, 2024|Medical Device News Magazine|
Rejuvenate Biomed and SAS Tap AI to Develop Disease-agnostic Drug Repurposing Discovery Toolsnews2024-08-01T10:43:22+00:00August 1st, 2024|Medical Device News Magazine|
Flagship Pioneering Unveils Abiologics to Pioneer Supranatural Biologics, A New Biotherapeutic Classnews2024-07-23T10:49:44+00:00July 23rd, 2024|Medical Device News Magazine|
Biolyst Scientific Announces New Brand Name to Encompass EMS and Azer | Will Deepen Offerings to Clinical and Research Lab Customersnews2024-07-23T10:30:36+00:00July 23rd, 2024|Medical Device News Magazine|
Avenacy Announces Launch of Palonosetron Hydrochloride Injection, USP in the U.S. Marketnews2024-07-22T14:15:37+00:00July 22nd, 2024|Medical Device News Magazine|
